Hims & Hers Health (HIMS) Equity Average (2019 - 2026)

Hims & Hers Health has disclosed Equity Average across 8 years of filings, most recently posting $493.5 million for Q1 2026.

• Equity Average for Q1 2026 came in at $493.5 million, down 3.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $493.5 million (down 3.79% YoY), and the FY2025 annual result was $508.8 million, up 23.99% from the prior year.
• Equity Average came in at $493.5 million for Q1 2026 at Hims & Hers Health, down from $561.0 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $571.8 million in Q3 2025 to a low of $311.3 million in Q4 2022.
• The 5-year median for Equity Average is $344.3 million (2024), against an average of $401.3 million.
• Peak annual rise in Equity Average reached 354.92% in 2022, while the deepest fall reached 9.73% in 2022.
• Hims & Hers Health's Equity Average stood at $311.3 million in 2022, then rose by 8.01% to $336.3 million in 2023, then surged by 36.3% to $458.4 million in 2024, then rose by 22.38% to $561.0 million in 2025, then retreated by 12.02% to $493.5 million in 2026.
• The last three Equity Average figures came in at $493.5 million (Q1 2026), $561.0 million (Q4 2025), and $571.8 million (Q3 2025), per Business Quant data.